The latest announcement is out from Phoenix Motor ( (PEVM)). On December 23, 2025, Phoenix Motor Inc. held its 2025 Annual Meeting of Stockholders, with approximately 82% of eligible shares ...

Timothée Chalamet and Kylie Jenner attempted to silence rumors they had split with a PDA-filled red carpet appearance. However, the couple's future appears more doom-and-gloom than hopeful based on ...

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease Results show, for the first time, that targeting underlying a-syn pathology with ...

Bel Power Solutions, a Bel group company (NASDAQ:BELFA and BELFB) and premier global manufacturer of power management devices, today announced a new DC-AC inverter, which offers a high efficiency ...

Katy Perry and her new boyfriend Justin Trudeau are in a good place. According to a source, the singer-songwriter, 41, and the former Canadian prime minister, 53, are “in the honeymoon phase” and ...

The second phase of widening Interstate 81 in Washington County, Maryland, will be split into two parts to keep the project on schedule. Construction for Phase 2A is expected to begin in 2027, with ...

Do you like Lionel, Marx, MTH, K-Line, Menards, and other 3-rail O gauge trains? Do you like big trains but have a small budget? This is the channel for you! Novices are welcome here! I received my ...

The Maxon Bikedrive Air is the sleek, neatly integrated mid-motor behind what has been billed for years as the world's lightest full-suspension electric mountain bike, the 14.8-kg (32.6-lb) Thömus ...

May 6 (Reuters) - India's Tata Motors (TAMO.NS), opens new tab said on Tuesday its shareholders have approved the company's plan to split the automaker into two listed companies, separating its ...

MORNING TO FOUR IN THE AFTERNOON. ALL RIGHT. MORE NEWS, CHANGES AT EPPLEY AIRFIELD DURING CONSTRUCTION MAY HAVE YOU WALKING OUTSIDE IN THE COLD. BOTH FLOORS OF THE MIDDLE OF THE TERMINAL ARE NOW ...

AC Immune SA plans talks with regulators based on positive interim safety and efficacy results from the phase II Vacsyn trial of its wholly owned anti-alpha-synuclein (a-syn) active immunotherapy ...